Cargando…
Utilization of drugs with reports on potential efficacy or harm on COVID‐19 before, during, and after the first pandemic wave
PURPOSE: Conflicting information on potential benefits of drugs as well as reports on hypothetical harm of commonly used drugs in COVID‐19 treatment have challenged clinicians and healthcare systems. We analyzed the change in ambulatory drug utilization before, during, and after the first wave of th...
Autores principales: | Enners, Salka, Gradl, Gabriele, Kieble, Marita, Böhm, Michael, Laufs, Ulrich, Schulz, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441787/ https://www.ncbi.nlm.nih.gov/pubmed/34245078 http://dx.doi.org/10.1002/pds.5324 |
Ejemplares similares
-
Quality Appraisal of Ambulatory Oral Cephalosporin and Fluoroquinolone Use in the 16 German Federal States from 2014–2019
por: Gradl, Gabriele, et al.
Publicado: (2021) -
Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia
por: Mahfoud, Felix, et al.
Publicado: (2022) -
Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany
por: Rudolph, Ulrike Maria, et al.
Publicado: (2020) -
Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012–2021
por: Katzmann, Julius L., et al.
Publicado: (2022) -
Assessment of the Prescriptions of Systemic Antibiotics in Primary Dental Care in Germany from 2017 to 2021: A Longitudinal Drug Utilization Study
por: Gradl, Gabriele, et al.
Publicado: (2022)